LONDON, March 16 /PRNewswire/ -- Millions of people already take a statin to lower their cholesterol and millions more are about to be prescribed these drugs under current guidelines. However, a new book provides substantial evidence to show that most people do not need to lower their cholesterol.
Using official statistics and references from medical literature, the author makes a strong case against the mass prescription of cholesterol-lowering drugs. The key findings in the book are:
- What is being suggested as 'high' cholesterol is in many cases simply a normal or average cholesterol level - Most people who have a heart attack do not have high cholesterol - their cholesterol tends to be average or below the average for the general population - Higher cholesterol does not correlate with a higher incidence of heart disease when we look at most countries around the world - The rate of heart disease continues to increase despite large reductions in the number of people with 'high' cholesterol - The average cholesterol level for people in the UK is low when compared with the rest of Europe. Despite this, the UK has one of the highest rates of heart attacks - The latest research has completely changed our understanding of heart disease and has led many researchers to abandon the idea that the arteries simply get clogged-up with fats - Foods that have been designed specifically to lower cholesterol have adverse effects that have not been communicated to consumers
The author describes how problems within medical research have allowed a general fear of cholesterol to develop and how the results from statin trials have been routinely exaggerated to imply greater benefits than were actually achieved.
The millions of people facing the decision of whether or not to take a statin will find the information in this book essential.
This is the first book on the subject that is genuinely accessible to the general reader; the new findings and scientific references will also be of use to those with a professional interest.
The author estimates the global cholesterol-lowering industry to be worth $29 billion and calls for a new approach to the prevention of heart disease.
Title: $29 Billion Reasons to Lie about Cholesterol: Making Profit by Turning Healthy People into Patients. By Justin Smith
ISBN: 9781848760714 Price GBP9.99 Contact: Justin Smith http://www.29billion.com info@29billion.com Phone +44(0)7817485038
Contact: Justin Smith, info@29billion.com, Phone +44(0)7817485038
Comments